Contractor
HIKMA PHARMACEUTICALS USA INC.
- UEI
- NQJ5E87TKNB1
- Parent UEI
- CH1CEGU3DW33
- Resolved by
- uei
- Confidence
- 1.000
Active from Aug 11, 2021 to Oct 6, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36C26027F0012 BULK XYREM | Department of Veterans Affairs | MO | Oct 6, 2026 | $177,244 |
| 75A50326C00012 FY26 SNS PHARMACEUTICAL LOGISTIC REPLENISHMENT - DIAZEPAM | Department of Health and Human Services | GA | Sep 30, 2026 | $7,521,325 |
| 36F79721D0213 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Aug 11, 2021 | — |
| 36E79726D0001 NEW AWARD FOR HYDRALAZINE HCL INJECTIONS WITH HIKMA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS 1/20/2026 - 1/19/2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Nov 21, 2025 | — |
| SPE2D326F088X 4571704565!DILTIAZEM 50 MG/10 ML VIAL 10ML | Department of Defense | NJ | May 4, 2026 | $137 |
| SPE2D326F088C 4571704566!DILTIAZEM 50 MG/10 ML VIAL 10ML | Department of Defense | NJ | May 4, 2026 | $183 |
| SPE2D326F034M 4571447012!HYDROMORPHONE 2 MG/ML VIALML | Department of Defense | NJ | Apr 17, 2026 | $38 |
| SPE2D326F019L 4571492071!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Apr 14, 2026 | $264 |
| SPE2D326F019R 4571492069!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Apr 14, 2026 | $440 |
| SPE2D326F9521 4571364610!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Apr 3, 2026 | $264 |
| SPE2D326F8807 4571313686!HYDROMORPHONE 2 MG/ML VIALML | Department of Defense | NJ | Mar 30, 2026 | $115 |
| SPE2D326F8589 4571264969!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Mar 25, 2026 | $220 |
| SPE2D326F8292 4571232734!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Mar 23, 2026 | $4,398 |
| SPE2D326F8102 4571190667!HYDROMORPHONE HYDROCH | Department of Defense | NJ | Mar 18, 2026 | $3,437 |
| SPE2D326F8067 4571171960!MORPHINE SULFATE 10 MG/ML VIALML | Department of Defense | NJ | Mar 17, 2026 | $1,759 |
| SPE2D020D0006 4610058780! | Department of Defense | — | Mar 11, 2026 | — |
| SPE2D326F6846 4571000048!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML | Department of Defense | NJ | Mar 2, 2026 | $113 |
| SPE2D025F0494 8511480715!OTHER MEDICAL | Department of Defense | NJ | Jul 8, 2025 | $30,031 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier NQJ5E87TKNB1, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.